The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

Co-led by new investors aMoon and Luma Group, Bausch + Lomb, Jefferson Life Sciences and others also participated in the funding, which will accelerate the advancement of pipeline precision therapies ...

Character Biosciences has raised $93m in an oversubscribed Series B round to speed the clinical development of a pipeline of ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, announced today an oversubscribed $93 million Series B financing round to accelerate the ...

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...

Incorporate omega-3s into your diet: Foods like fish have been shown to reduce the risk of macular degeneration. Don’t forget to add a handful of walnuts to your meals as they’re also packed with ...

The "Dry Age-Related Macular Degeneration - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. The "Dry AMD -Epidemiology - 2034" report delivers an in-depth ...

Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB) Phase 2 SHINE Data Show Dramatic Slowing of Cognitive Decline with Zervimesine in a Key Pre-specified ...

Dry age-related macular degeneration (AMD) significantly affects patients' daily activities and quality of life, regardless of visual impairment.

The ReNEW study for dry AMD is evaluating the efficacy, safety, and pharmacokinetics of daily subcutaneous injections of ...

Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in ...